On Friday, June 26, 2026, German Chancellor Friedrich Merz visited the Salutas Pharma facility in Magdeburg. The site, part of Hexal AG under the Swiss drugmaker Sandoz, produces roughly ten billion capsules and tablets a year, many for cancer treatment, and exports worldwide. Merz praised the modern, adaptable plant as a “stand‑out example of future‑proof jobs” in eastern Germany. He highlighted the pharmaceutical sector’s role in ensuring a reliable supply of essential medicines for Germany and Europe. The chancellor said the federal government will improve the industry’s framework and strengthen its resilience and competitiveness, both nationally and within the EU. This visit underscores the government’s commitment to industrial health and job creation in the region.
Made by AI. If you spot anything of concern write us at contact@cybach.com. We’ll promptly correct irregularities.